News | News By Subject | News by Disease News By Date | Search News

Emphysema News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News

News from Around the Web
Implantable Air Valves Help Some Emphysema Patients Breathe Easier, University of Groningen Study     12/10/2015
New Research Uncovers Genetic Link Between Emphysema, Lung Cancer, UT Southwestern Medical Center Study     6/9/2011
Protein Could Offer Target to Reduce Lung Damage from Smoking-Caused Emphysema, Indiana University Study     5/17/2011
Protecting the Lungs Against 'Collateral Damage' from the Immune System, University of Alabama at Birmingham Study     9/3/2010
Drug Shields Mice From Chronic Lung Disease, Johns Hopkins University School of Medicine Study     12/23/2008
Life Science Weekly inSite (Sep. 21 - 26)     9/29/2008
Older Emphysema Drug Linked To Heart Deaths, Northwestern University Study     9/17/2008
Acne Drug Doxycycline Prevents Tissue Damage From Emphysema, Leeds University and University of California, San Diego (UCSD) Study     5/16/2008
Combination Therapy Reduces Emphysema Flare-Ups     1/24/2007
FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs     8/11/2006
Wrinkles "Linked To Lung Disease"     6/14/2006
Tomato Juice Keeps Emphysema From Developing In New Model; Lycopene Cited     1/9/2006
Johnny Carson Dies From Common Lung Disease     1/25/2005
Bone Loss Seen With Lung Disease Treatment     1/3/2005
Gene Found To Defend Against Environmental Pollutants And Pulmonary Emphysema     11/11/2004

Press Releases
New Study Demonstrates Benefits Of Pulmonx, Inc. Zephyr Endobronchial Valve In Patients With Homogeneous Emphysema     9/6/2016
Shire (SHPG) And Kamada Ltd. (KMDA) Announce FDA Approval Of Expanded Label For Self-Infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency     6/15/2016
Uptake Medical Release: Intervapor Targeted Ablation Therapy Reported As Superior To Standard Medical Management In The Lancet     3/1/2016
Pulmonx, Inc. Completes Enrollment Of Randomized, Prospective, Multi-Center Study In New Patient Population     1/14/2016
The New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits Of Pulmonox Medical’s Medical Device For Emphysema     12/10/2015
Data Confirms Uptake Medical’s InterVapor Significantly Improves Lung Function in Severe Emphysema Patients     10/2/2015
Uptake Medical Receives CE Mark Approval For InterVapor Targeted Ablation Therapy For Severe Emphysema     8/12/2015
Lancet Publication Of Sham-Controlled Clinical Trial Shows Pulmonx, Inc.’s Zephyr Endobronchial Valves Deliver Significant Benefit To Emphysema Patients     7/1/2015
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia®     4/24/2014
Kamada Ltd. (KMDA.TA) Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency     12/11/2013
INNOPHARMA Announces FDA Approval of Acetylcysteine Solution, USP, 20% for Inhalation or Oral Administration     9/19/2012
Study Shows Revolutionary New Treatment from Pulmonx, Inc. is Consistently Effective in Treating Emphysema     5/25/2011
Talecris Biotherapeutics (TLCR): Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema     11/15/2010
BioRx Enters the Alpha-1 Specialty Home Infusion Market     10/13/2010
Pulmonx, Inc. Reports Scientific Publication and Presentations Highlighting Key Advances in Emphysema Treatment     9/28/2010